A study to compare the effectiveness of three different insulin combinations to control blood sugars in patients with type 2 diabetes mellitus in patients admitted to the hospital wards.

Efficacy of three different insulin combination in achieving control of hyperglycaemia in non-critically ill hospitalised patients with type 2 diabetes - A randomized control trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/04/024789

Enrollment

171

Registered

2020-04-22

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: Insulin analogues (Glargine and Glulisine): It is a three arm trial Intervention arm 1- Basal and bolus regime of once daily Glargine with thrice daily Glulisine Intervention arm 2- Ba

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients with established type 2 diabetes mellitus admitted to the medical unit and expected to stay in the hospital for atleast 3 days. Adult patients without history of Diabetes but found to have CBG >200mg/dL or HbA1C >6.5% admitted to the medical unit and expected to stay in the hospital for atleast 3 days.

Exclusion criteria

Exclusion criteria: Age Type 1 Diabetes Pregnant women Patients on enteral feeds Patients on corticosteroids Patients admitted to IMCU/ICU Patients with renal dysfuction (eGFR <30ml/min/1.73sq.m)

Design outcomes

Primary

Measure	Time frame
Efficacy of glycaemic control measured by the mean daily blood glucoseTimepoint: 3 months	—

Secondary

Measure	Time frame
Cost of insulin therapyTimepoint: 3 weeks;Incidence of hypoglycaemia (CBG below 70mg/Dl) with or without symotoms.Timepoint: 3 weeks;Length of hospital stayTimepoint: 3 months;Severe hyperglycaemia with CBG more than 400mg/dL or that requiring IV insulin correctionTimepoint: 3 months	—

Countries

India

Contacts

Public ContactNayan Sri

Sundaram medical foundation Dr. Rangarajan memorial hospital

girijasuresh59@gmail.com9283127335

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026